Viewing Study NCT05005559


Ignite Creation Date: 2025-12-24 @ 3:02 PM
Ignite Modification Date: 2026-01-03 @ 7:42 AM
Study NCT ID: NCT05005559
Status: COMPLETED
Last Update Posted: 2022-10-13
First Post: 2021-08-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase III Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen)
Sponsor: Cinnagen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Covid19 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None COVID-19 View
None SARS-COV-2 View
None Recombinant protein View
None Spike View
None Advax-SM View
None Advax View
None Vaccine View
None Adjuvant View